Shares of Tonix Pharmaceuticals are pulling back 12.7% during Thursday's session. The stock is pulling back following a regulatory update on its experimental fibromyalgia treatment, TNX-102 SL.

Labour's Work and Pensions Secretary Liz Kendall announced major shake-up plans for the welfare system, with huge changes ...

In a class action loss against Bayer for harms caused by its Essure contraceptive device, some saw familiar failures of ...

The researchers discovered that a simple, non-surgical procedure called genicular nerve radiofrequency ablation can ...

Jason, a 42-year-old father of two, has been battling back pain for weeks. Scrolling through his phone, he sees ad after ad ...

Some forms of exercise training and pharmacological-based interventions may improve fibromyalgia-related sleep disturbances, though evidence is limited.

The following is a summary of “Understanding patients’ perceptions of uncomplicated low back pain: a theory-informed ...

A copy of the Company’s poster will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be ...

With spring in full swing, momentum is growing around the property market – with many experts predicting a summer boom.

Arialief offers a satisfaction guarantee, allowing customers to try the product risk-free. If users do not experience the ...

Disabled people and allies just came out in communities nationwide to fight the DWP cuts from Canary on 27 March 2025 ...

Your home office isn't just a place where you work; you practically live there. But let's be honest: long work hours can take a toll. A study published in Frontiers in Public Health found that up to ...